Genscript shares jump after FDA approves emergency use of Covid-19 test kit

Genscript Biotech claims its cPass kit is the first commercially available test to specifically detect neutralising antibodies without the use of live virus.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *